Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05254574 · ClinicalTrials.gov registry record · Phase 1
Sustained Acoustic Medicine for Osteoarthritis Pain
A Phase 1 study of Osteoarthritis, sponsored by ZetrOZ.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT05254574 is a Phase 1 study of Osteoarthritis that is actively recruiting participants, run by ZetrOZ. The registered enrollment target is 200 participants, below the 816-participant average among 135 other Osteoarthritis trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05254574, a Phase 1 study of Osteoarthritis, is actively recruiting participants, sponsored by ZetrOZ.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare Sustained Acoustic Medicine treatment to topical pain relief gel for the symptomatic management of osteoarthritis. The study will measure pain and function scores for patients undergoing treatment.
Conditions Studied
Interventions
- DEVICE Sustained Acoustic Device with 2.5% Diclofenac Patch
- DRUG 2.5% Diclofenac Patches
Study Locations (1)
Florida
- James A Haley Veterans Hospital - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-02-14 |
| Est. Completion | 2026-05-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05254574
The ClinicalTrials.gov registry entry for NCT05254574 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 816-participant average among 135 other Osteoarthritis trials with a reported enrollment target (75% lower). The listed sponsor is ZetrOZ, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which Sustained Acoustic Device with 2.5% Diclofenac Patch is the first listed.
NCT05254574 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT05254574 about?
NCT05254574 is a clinical study titled "Sustained Acoustic Medicine for Osteoarthritis Pain". The purpose of this study is to compare Sustained Acoustic Medicine treatment to topical pain relief gel for the symptomatic management of osteoarthritis. The study will measure pain and function scores for patients undergoing treatment.
What is the current status of trial NCT05254574?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 200 participants. The study started on 2022-02-14. Estimated completion is 2026-05-31.
What conditions does trial NCT05254574 study?
This clinical trial studies the following conditions: Osteoarthritis.
What interventions are being tested in trial NCT05254574?
The interventions under investigation include: Sustained Acoustic Device with 2.5% Diclofenac Patch (DEVICE), 2.5% Diclofenac Patches (DRUG).
Who is sponsoring clinical trial NCT05254574?
This trial is sponsored by ZetrOZ, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05254574 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study With GLPG1972 in Osteoarthritis Subjects
COMPLETED · Phase 1
-
Autologous Alpha-2 Macroglobulin Rich Plasma, Safety and Efficacy in Symptomatic Moderate Knee Osteoarthritis
COMPLETED · Phase 1
-
Translating Metabolic Responses to Mechanical Insult Into Early Interventions to Prevent PTOA
COMPLETED · Phase 1
-
Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Knee
RECRUITING · Phase 2
-
A Prospective, Post-Market, Clinical Follow-up Study of the Incompass™ Total Ankle System
RECRUITING
-
Reliability of Pupil Response to Acute Pain
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.